BACKGROUND: Current outcomes from catheter ablation for scar-dependent ventricular tachycardia (VT) are limited by high ...

Hello and welcome to this week's edition of Circulation on the Run. My name is Dr. Pishoy Gouda from the University of Alberta, and I'm joined today with Dr. Alexander Fanaroff from the University of ...

Abstract We investigated the effects of angiotensin II (Ang II) type 1 receptor blockade with losartan on the renin-angiotensin-aldosterone system in hypertensive patients (supine diastolic blood ...

From Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville Campus, Victoria, Australia (R.H.R.) Division of Endocrinology and Metabolism (E.D.A.), ...

Our vision is to innovate and incorporate promising technologies to communicate freely available, high-priority, high-quality content, which accelerates scientific progress and advances heart and ...

Figure 1. Signal transduction mechanism of EGFR (epidermal growth factor receptor) transactivation by angiotensin II (AngII) in vascular smooth muscle cells leading to vascular remodeling. Please note ...

Noninducibility of any VT at PES* Established predictive value when performed from multiple sites (RV and LV) ≤3 extrastimuli Not useful for patients without inducible VT; suboptimal negative ...

The optimal grading scale must demonstrate (1) a strong correlation with clinical outcome, (2) simplicity and feasibility of scale interpretation while ensuring characterization of relevant ...

Although the role of longer-term BP control to improve outcomes in patients with stroke is undisputed, BP management immediately after a stroke remains controversial. In an effort to resolve this ...

In this perspective, we review 3 areas in which cardiology should reconsider current practices, and carefully consider studies in the future to address this important concern. Given the revolution in ...